Small Cell Lung Cancer (SCLC) Vs Non-Small Cell Lung Cancer (NSCLC): Quick...
Cancer that is formed in the tissues of the lungs (lung cancer) are classified into two main types, small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) based on how the cancer cells...
View ArticleNon-Small Cell Lung Cancer Therapy Enhanced – Combination Of RNAi With...
New research published in the journal BMC Medicine, and titled, ‘Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with...
View ArticleGefitinib Improves Survival In Non-Small Cell Lung Cancer Maintenance...
A new study on maintenance treatment for patients with advanced non-small cell lung cancer (NSCLC) has found that Gefitinib prolongs cancer progression-free survival after first-line chemotherapy. The...
View ArticleAre Elderly Lung Cancer Patients Being Written Off: New Study By Dr. Wang
A new study finds that older patients with non-small cell lung cancer are less likely to be treated when compared to younger patients irrespective of their overall health and prognosis. The study in...
View ArticleLUNG CANCER At ASCO: DOCETAXEL BETTER THAN ERLOTINIB FOR NSCLC – TAILOR STUDY
I have been writing on T-DM1, PD1 blockers, prostate cancer at the ASCO and am feeling guilty on having neglected lung cancer, the cancer that we are following this month on CureTalk. Therefore, I am...
View ArticleCrizotinib (Xalkori) Mechanism of Action and ALK Fusion Genes In NSCLC
Pfizer’s Xalkori (Crizotinib) has been found to increase progression free survival in lung cancer patients with ALK mutations who have been previously treated. Crizotinib was approved by the FDA in...
View ArticleClik here to view.
Small Cell Lung Cancer (SCLC) Vs Non-Small Cell Lung Cancer (NSCLC): Quick...
Lung Cancer has the highest mortality among cancers. Cancer that is formed in the tissues of the lungs (lung cancer) are classified into two main types, small cell lung cancer (SCLC) and non-small cell...
View ArticleClik here to view.
Non-Small Cell Lung Cancer Therapy Enhanced – Combination Of RNAi With...
Combination of iRNA and TKI offer new dimensions to lung cancer therapy. Pic courtesy: http://www.nature.com/scitable/topicpage/gene-expression-14121669 New research published in the journal BMC...
View ArticleClik here to view.
Gefitinib Improves Survival In Non-Small Cell Lung Cancer Maintenance...
Gefitinib prolongs progression free survival. Pic courtesy: http://www.nature.com/nrd/journal/v2/n7/fig_tab/nrd1136_F1.html A new study on maintenance treatment for patients with advanced non-small...
View ArticleClik here to view.
Are Elderly Lung Cancer Patients Being Written Off: New Study By Dr. Wang
A new study shows that older lung cancer patients are less likely to receive treatment when compared to younger patients. A new study finds that older patients with non-small cell lung cancer are less...
View ArticleClik here to view.
LUNG CANCER At ASCO: DOCETAXEL BETTER THAN ERLOTINIB FOR NSCLC – TAILOR STUDY
Erlotinib is not as effective as docetaxel in NSCLC patients without EFGR mutations. Pic courtesy: http://commons.wikimedia.org/ I have been writing on T-DM1, PD1 blockers, prostate cancer at the ASCO...
View ArticleClik here to view.
Crizotinib (Xalkori) Mechanism of Action and ALK Fusion Genes In NSCLC
Crizotinib bound to ATP binding pockets in ALK protein. Pfizer’s Xalkori (Crizotinib) has been found to increase progression free survival in lung cancer patients with ALK mutations who have been...
View Article
